Absorption |
Blood-Brain Barrier | BBB+ | 0.6232 |
Human Intestinal Absorption | HIA+ | 0.9774 |
Caco-2 Permeability | Caco2+ | 0.6384 |
P-glycoprotein Substrate | Substrate | 0.7665 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9861 |
Non-inhibitor | 0.9729 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9107 |
Distribution |
Subcellular localization | Mitochondria | 0.6120 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7044 |
CYP450 2D6 Substrate | Non-substrate | 0.8247 |
CYP450 3A4 Substrate | Substrate | 0.5154 |
CYP450 1A2 Inhibitor | Inhibitor | 0.7660 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8937 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9007 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7246 |
CYP450 3A4 Inhibitor | Inhibitor | 0.7682 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8975 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9040 |
Non-inhibitor | 0.8444 |
AMES Toxicity | Non AMES toxic | 0.8792 |
Carcinogens | Non-carcinogens | 0.9616 |
Fish Toxicity | High FHMT | 0.9724 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9973 |
Honey Bee Toxicity | High HBT | 0.7104 |
Biodegradation | Ready biodegradable | 0.5709 |
Acute Oral Toxicity | III | 0.3986 |
Carcinogenicity (Three-class) | Non-required | 0.6604 |